Creating precision therapies from the immune response

Atreca is a biotechnology company that is using our proprietary human antibody discovery platform to develop a pipeline of novel cancer antibodies that can enhance and direct the therapeutic effects... Learn more >


A novel class of immuno-oncology therapeutics that direct and enhance checkpoint inhibition

More +

IRC TEchnology

Our proprietary immune profiling technology provides unparalleled insight

More +

Who is Atreca?

A dedicated team of molecular biologists, immunologists, drug developers and computational biologists

More +